Company Filing History:
Years Active: 1995-1996
Title: The Innovations of Jean-Pierre Van Hoeck
Introduction
Jean-Pierre Van Hoeck is a notable inventor based in Chastre, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic agents. With a total of 3 patents to his name, his work has had a meaningful impact on pain management therapies.
Latest Patents
Van Hoeck's latest patents include innovative compounds that are designed to alleviate pain. One of his notable inventions is the "Substituted dibenzoxazepine compounds and methods for treating." This invention provides dibenzoxazepine compounds of Formula I, which are useful as analgesic agents for the treatment of pain. The pharmaceutical compositions comprise a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier. Additionally, the method for eliminating or ameliorating pain in an animal involves administering a therapeutically-effective amount of a compound of Formula I to the animal. Another patent, "Substituted dibenzoxapine compounds, pharmaceutical compositions and," also focuses on similar applications, emphasizing the therapeutic potential of these compounds.
Career Highlights
Jean-Pierre Van Hoeck has been associated with G.D. Searle & Company, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and treatment of pain through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Van Hoeck has collaborated with esteemed colleagues, including E Ann Hallinan and Timothy J Hagen. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.
Conclusion
Jean-Pierre Van Hoeck's contributions to the field of pharmaceuticals, particularly in pain management, highlight his role as a significant inventor. His innovative patents and collaborations continue to influence the development of effective analgesic agents.